24 August 2020 : Laboratory Research
Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells
DOI: 10.12659/MSM.924922
Med Sci Monit 2020; 26:e924922
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
24 August 2020 : Laboratory Research
DOI: 10.12659/MSM.924922
Med Sci Monit 2020; 26:e924922
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.